science

Pharmacogenomics annotation

Pharmacogenomics annotation is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pharmacogenomics annotation rather than just read about it. In short: Pharmacogenomics annotation refers to the use of genomic data as input to generate clinical recommendations tailored to the individual genotype. Examples of pharmacogenomics annotation tools are PharmCAT, PAnno, and PharmVIP.

Key takeaways

Pharmacogenomics annotation belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Pharmacogenomics annotation to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Pharmacogenomics annotation from memory before moving on to harder problems.

Reference excerpt

Pharmacogenomics annotation refers to the use of genomic data as input to generate clinical recommendations tailored to the individual genotype. Examples of pharmacogenomics annotation tools are PharmCAT, PAnno, and PharmVIP. For those three tools, genomic data is inputted as a Variant Call Format (VCF) file, and the output is the corresponding prescribing recommendations.

Background

Pharmacogenomics Pharmacogenomics is a field of study combining pharmacology with genomics. It seeks to tailor drug prescribing to individual patients using, in part, genotyping data from those patients. Individuals may possess genetic variants (differences in their DNA) that may alter the pharmacokinetics (PK; the way that drugs are absorbed, distributed to tissues, metabolized, and excreted) or pharmacodynamics (PD; how the drug interacts with its receptor) of specific drugs. Alterations in pharmacokinetics or pharmacodynamics can impact the effectiveness of pharmacological interventions, even in non-pharmacogenomic contexts. Pharmacogenomics research has benefitted from the adoption of Next Generation Sequencing (NGS) technologies, which enable higher-throughput methods of identifying pharmacologically relevant variants. Through research into these variants, both clinicians and researchers have found that modifying the doses of drugs can be effective for treating patients carrying variants affecting their PK and PD. Prescribing recommendations already exist for certain variants that have been identified through prior research into genetic predictors of drug effectiveness and side effects.

Star alleles Clinically actionable haplotypes are referred to in the literature as star (*) alleles. Haplotypes are groups of variants that are inherited together, due to being physically close on the same chromosome, reducing the chance of crossover during meiosis. Star alleles are of particular interest in pharmacogenomics due to their clinical utility. Pharmacogene diplotypes are generated from the maternal and paternal star alleles, and represent the combination of parental haplotypes.

Variant call format Genomic data is inputted as a VCF File. VCF Files are one type of file format used in bioinformatics. They can be generated from genomic data through separate bioinformatics software.

Annotation Pharmacogenomics annotation also relies on genes and variants being annotated. Annotation in the genetics context means matching DNA sequences to a corresponding gene, protein, or variant. Pharmacogenomics annotation tools do exactly that, but with an extra step - they match a specific sequence (or inferred haplotype) with a phenotype, which in turn is matched to a set of corresponding dosing or prescribing recommendations.

Implementation of pharmacogenomics in clinical settings Initiatives have sought to formulate plans, guidelines, and recommendations for implementing pharmacogenomic testing and personalized drug prescribing into clinical settings. Pharmacogenomics faces a number of obstacles to successful implementation into clinical practice - notably, cost to sequence, lack of knowledge/education on the subject, and lack of approachability. These tools seek to address, in part, this lack of approachability through software platforms that take in genomic data and output relevant and actionable clinical recommendations.

Use The general workflow for pharmacogenomics annotation consists of two steps:

Processing and allele determination Matching pharmacogenomic phenotypes to diplotypes The first phase consists of a preprocessing step and an allele determination step. This preprocessing step removes extraneous information and downloads the corresponding human reference genome sequence. It then formats the file to the standardized format. The allele determination step matches inputted genotypes to named alleles. If the inputted data is phased, the step can match diplotypes without extra computation steps. If the data is unphased, the software will go through additional steps to attempt to correctly match alleles. The second phase also has two steps: matching phenotypes and report generation. The phenotype matching step matches the diplotypes generated in the first phase to known pharmacogenomic phenotypes (like metabolizer status, discussed below). The report generation step compiles all of the information generated in that previous step into a comprehensive report. Different tools will differ in terms of how that report is generated and presented, as shown in the table below.

Limitations Like any bioinformatics tools or methods, the quality of the output from these tools depends largely on the quality and type of the inputted data. Low quality data can result from repetitive sequences, as NGS technologies still struggle with identifying repetitive sequences. This in turn leads to low accuracy in genes involved in those regions, such as UGT1A1. This would result in lower accuracy of the output report. As with the input data, output quality depends on genes and variants being annotated correctly and comprehensively, which in turn depends on research previously conducted examining those variants and their effects on response to drugs. Generalizability to different populations also depends on the amount and quality of pharmacogenomics research conducted on those populations. Historical underrepresentation has resulted and continues to result in a lack of data in genomics. As a result of this lack of data, historically underrepresented populations are the least likely to see benefit from personalized treaments. In addition, while tools may be able to parse non-SNP variants, VCF files generally do not incorporate copy number or structural variants. As such, that information will not be translated into drug response phenotypes or prescribing recommendations. Structural variation has been estimated to account for approximately 22% of pharmacogenomic variability. Excluding structural variation (and the accompanying 22% of pharmacogenomic variability) would therefore result in potentially inaccurate recommendations.

Comparison PharmCAT, PAnno, and PharmVIP are pharmacogenomics annotation tools designed to analyze sequenced or genotyped genomic data (in VCF or BAM format) to predict individual drug responses, based on genetic profiles. The key difference between these tools lies in their respective use cases:

… excerpt ends here. Continue reading the full article.

Worked examples

Example 1 — a first encounter with Pharmacogenomics annotation

Start with the simplest possible case. Write down what Pharmacogenomics annotation claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pharmacogenomics annotation before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pharmacogenomics annotation ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pharmacogenomics annotation

In research: Pharmacogenomics annotation appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Pharmacogenomics annotation in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Pharmacogenomics annotation is common in secondary-school and first-year university syllabi. It links to neighbouring topics Pharmacogenomics, so understanding it makes those chapters shorter.
In everyday life: Look for Pharmacogenomics annotation outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pharmacogenomics annotation in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Pharmacogenomics annotation means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Pharmacogenomics annotation out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pharmacogenomics annotation in simple terms?

Why does Pharmacogenomics annotation matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pharmacogenomics annotation?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pharmacogenomics annotation.